NO920747L - 1,2,4-benzotriazinoksider som radiosensibiliserende midler og selektive cytotoksiske midler - Google Patents

1,2,4-benzotriazinoksider som radiosensibiliserende midler og selektive cytotoksiske midler

Info

Publication number
NO920747L
NO920747L NO92920747A NO920747A NO920747L NO 920747 L NO920747 L NO 920747L NO 92920747 A NO92920747 A NO 92920747A NO 920747 A NO920747 A NO 920747A NO 920747 L NO920747 L NO 920747L
Authority
NO
Norway
Prior art keywords
morpholino
opt
alkyl
piperidino
alkoxy
Prior art date
Application number
NO92920747A
Other languages
English (en)
Other versions
NO920747D0 (no
NO305905B1 (no
Inventor
William W Lee
J Martin Brown
Edward W Grange
Aberlardo P Martinez
Michael Tracy
Daniel J Pollart
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of NO920747L publication Critical patent/NO920747L/no
Publication of NO920747D0 publication Critical patent/NO920747D0/no
Publication of NO305905B1 publication Critical patent/NO305905B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Artificial Fish Reefs (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO920747A 1989-09-18 1992-02-25 Analogifremgangsmåte for fremstilling av et 1,2,4-benzotriazinoksid NO305905B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/004112 WO1991004028A1 (en) 1989-09-18 1989-09-18 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Publications (3)

Publication Number Publication Date
NO920747L true NO920747L (no) 1992-02-25
NO920747D0 NO920747D0 (no) 1992-02-25
NO305905B1 NO305905B1 (no) 1999-08-16

Family

ID=22215243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920747A NO305905B1 (no) 1989-09-18 1992-02-25 Analogifremgangsmåte for fremstilling av et 1,2,4-benzotriazinoksid

Country Status (10)

Country Link
EP (1) EP0478545B1 (no)
JP (1) JP3034541B2 (no)
KR (1) KR0142858B1 (no)
AT (1) ATE183094T1 (no)
AU (1) AU646794B2 (no)
DE (1) DE68929050T2 (no)
FI (1) FI111008B (no)
HU (2) HU221201B1 (no)
NO (1) NO305905B1 (no)
WO (1) WO1991004028A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672702A (en) * 1995-12-04 1997-09-30 Sanofi Process for preparing 3 amino 1, 2, 4-benzotriazine dioxide
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
NZ521436A (en) * 2002-09-17 2005-07-29 Auckland Uniservices Ltd DNA- targeted benzotriazine 1,4-dioxides and their use in cancer therapy
EP1723125A4 (en) 2004-03-01 2009-11-18 Auckland Uniservices Ltd 1,2,4-benzotriazine-1,4-dioxides
JP2015500295A (ja) * 2011-12-07 2015-01-05 エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ ヒト結核菌を標的とする医薬としてのベンゾトリアジンオキサイド類
JP2015084923A (ja) * 2013-10-30 2015-05-07 テクナード株式会社 衣服用防湿マット
CN111372940A (zh) * 2017-09-19 2020-07-03 阿尔伯塔大学理事会 生物还原活化的化合物、其前药、放射性药物、组合物及其在包括癌症在内的低氧疾病的多模式治疗控制中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079390A (en) 1958-12-12 1963-02-26 Searle & Co N-substituted 3-amino-1, 2, 4-benzotriazine-1-oxides
BE794742A (fr) 1972-02-01 1973-07-30 Bayer Ag Nouveaux di-n-oxydes (1,4) de benzo-1,2,4-triazine, leur procede de preparation et leur application comme medicaments et additifs de nutrition
US3980779A (en) 1972-02-01 1976-09-14 Bayer Aktiengesellschaft 3-Amino-1,2,4-benzotriazine-1,4-di-N-oxide compositions and method of using same
US4001410A (en) 1972-02-01 1977-01-04 Bayer Aktiengesellschaft 3-amino-1,2,4-benzotriazine-1,4-di-n-oxide compositions and method of using same
US3991189A (en) 1972-11-15 1976-11-09 Bayer Aktiengesellschaft Microbiocidal methods and compositions using substituted 1,2,4-triazine-1,4-di-N-oxide derivatives
US4027022A (en) 1972-11-15 1977-05-31 Bayer Aktiengesellschaft Antibacterial benzo-1,2,4-triazines
IL44058A (en) 1973-02-02 1978-10-31 Ciba Geigy Ag 3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
US3957799A (en) 1973-04-04 1976-05-18 E. R. Squibb & Sons, Inc. Sulfur containing amino and imino pyridines
US4022022A (en) * 1976-04-26 1977-05-10 Parker-Hannifin Corporation Hydraulic system and control valve assembly therefor
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
DE2910974A1 (de) 1979-03-21 1981-02-19 Bayer Ag 3-sulfonyl-benzo-1,2,4-triazine und -benzo-1,2,4-triazin-1-oxide, verfahren zu ihrer herstellung sowie ihre verwendung als antimikrobielle mittel
US4371540A (en) 1979-09-14 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroimidazoles of low toxicity and high activity as radiosensitizers of hypoxic tumor cells
GB2203151B (en) 1986-09-25 1991-05-29 Stanford Res Inst Int 1,2,4-benzotriazine oxides as radiosensitisers and selective cytotoxic agents
IE62911B1 (en) 1988-03-18 1995-03-08 Stanford Res Inst Int 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Also Published As

Publication number Publication date
DE68929050T2 (de) 2000-02-03
DE68929050D1 (de) 1999-09-16
KR0142858B1 (en) 1998-07-15
FI920712A0 (fi) 1992-02-19
HU225965B1 (en) 2008-01-28
KR927003062A (ko) 1992-12-17
JPH05500499A (ja) 1993-02-04
JP3034541B2 (ja) 2000-04-17
AU646794B2 (en) 1994-03-10
EP0478545A4 (en) 1992-08-05
EP0478545A1 (en) 1992-04-08
ATE183094T1 (de) 1999-08-15
NO920747D0 (no) 1992-02-25
WO1991004028A1 (en) 1991-04-04
NO305905B1 (no) 1999-08-16
EP0478545B1 (en) 1999-08-11
HU9602225D0 (en) 1996-10-28
HU221201B1 (en) 2002-08-28
FI111008B (fi) 2003-05-15
AU4428489A (en) 1991-04-18

Similar Documents

Publication Publication Date Title
ATE188216T1 (de) Therapeutische mittel für die parkinsonsche krankheit
ZA958895B (en) Piperidine compounds process for their preparation and the pharmaceutical compositions which contain them
PT82673A (fr) Amides derives de la quinoleine procedes pour leur preparation et medicaments les contenant
DK0776324T3 (da) Endothelin-antagonister
ECSP034904A (es) Derivados de índole naftil sustituido como inhibidores del activador plasminogen del inhibidor tipo-1 (pai-1)
DE69131317D1 (de) HIV-Proteaseinhibitoren
FI913045A (fi) Heterocyklenderivat.
NO920747L (no) 1,2,4-benzotriazinoksider som radiosensibiliserende midler og selektive cytotoksiske midler
ATE218126T1 (de) Phenylpiperidin-derivate
ATE178056T1 (de) Substituierte tertiäre amine und deren salze
AR015233A1 (es) Sulfonamidas, proceso para su preparacion, composiciones farmaceuticas que las comprenden y el uso de las mismas para la fabricacion de medicamentos parael tratamiento de trastornos tromboembolicos.
DK291488D0 (da) Alkansulfonanilidderivater
FI803356L (fi) Nya azepinoindoler deras framstaellning och dessa innehaollande farmaceutiska foereningar
HUT60629A (en) Process for producing pharmaceutical compositions applicable as radiation sensitizer and selective cytotoxic agent and comprising 1,2,4-benzotriazine oxides as active ingredient
DE3864211D1 (de) 1,4-disubstituierte 1-azolyl-3,3-dimethylbutan-derivate.
GB2203151A (en) 1,2,4, benzotriazine oxides as radio sensitizers and selective cytotoxic agents
DK0792875T3 (da) Cryptophycinderivater og deres anvendelse som antimikrotubulusmidler
ES2057101T3 (es) Agente terapeutico para las enfermedades del higado y derivados de la piperazina.
AR041556A1 (es) Compuestos de 1- aril - dihidropiridona con actividad antimicrobiana
AR248402A1 (es) Procedimiento para la preparacion de 4-/3-(4-oxotiazoldinil)/butinilaminas utiles como medicamentos.
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
YU36391A (sh) Hibricidno aktivni derivati uree i postupak za njihovo dobijanje
FR2043463A1 (en) Benzoxazines and benzothiazines having c n s and
MX9604072A (es) Derivados de oxazolidinona y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
MK1K Patent expired